LSD Microdosing for Mood & Mental Health

Few substances in modern history have carried as much intrigue, controversy, and potential as LSD.

First synthesized in 1938 by Swiss chemist Albert Hofmann, LSD quickly became both a subject of scientific fascination and a catalyst for cultural exploration.

In the 1950s and 1960s, it was studied in the United States and beyond for its potential in treating depression, anxiety, and addiction, while simultaneously inspiring music, art, and countercultural movements, until prohibition halted nearly all research for decades.

Today, a new era of LSD research for mental health is emerging. At the forefront of this renaissance are Professor Suresh Muthukumaraswamy and Dr. Rachael Sumner, researchers at the University of Auckland in New Zealand, leading the world’s first government-sanctioned clinical trials of LSD microdosing for mood disorders.

📣 Join Our Live Webinar

Join Microdosing Collective and Third Wave’s live webinar with Professor Suresh Muthukumaraswamy and Dr. Rachael Sumner for an inside look at pioneering LSD microdosing research and what it could mean for the future of mental health.

📆 Wednesday, October 22nd, 2025
⏰ 12:00 PM PST | 3:00 PM EST
💬 60 minutes + Live Q&A
💻 Online | Free to attend

Can’t make it live? Register anyway and we’ll send you the full recording!

What We’ll Explore:

🧠 Key findings from New Zealand’s first government-sanctioned, at-home LSD microdosing trial
🍄 The neuroscience of microdosing and how sub-hallucinogenic doses influence brain activity, mood, cognition, and well-being
🔬 What clinical studies are revealing about LSD’s antidepressant potential
🚀 The future of LSD microdosing for depression, anxiety, and mood disorders
💬 Live Q&A with Drs. Muthukumaraswamy and Sumner to address your most pressing questions

🔬 Join the First Microdosing Study for Neuroplasticity

Research has long shown that single, high-doses of psychedelics can rewire the brain and enhance neuroplasticity. Now, it’s time to show the same for microdosing.

Psynautics' latest study is closing that gap, and your participation can help shape the future of psychedelic science. You will receive a Muse EEG headband in your Psynautics Study Kit for use during your microdosing protocol.

- With love from team Microdosing Collective 🍄

Was this email forwarded? Subscribe to get the next one delivered right to you!

DISCLAIMER: This newsletter is intended for educational and informational purposes only and should not be considered a replacement for professional medical advice. Always consult your healthcare provider before making changes. The Microdosing Collective does not promote the use of any illegal substance. Please be aware that the use, possession, and distribution of psychedelic substances are illegal in many countries and could lead to legal consequences.